Rocket Pharmaceuticals Completes Acquisition of Renovacor
CRANBURY, N.J.--(BUSINESS WIRE)--Dec. 1, 2022-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company...
Search for Articles
Dec 1, 2022
Nov 30, 2022
Broadview Ventures Appoints Cardiovascular Leader and Biotech Executive Michael Mendelsohn, MD to its Strategic Advisory Board
BOSTON – November 30, 2022 – Broadview Ventures, a mission-driven, cardiovascular health-focused investment organization, today announced...
Nov 23, 2022
Nyra Medical Announces $20 Million Series A Financing for its Transcatheter Heart Valve Repair Technology
ATLANTA, Nov. 23, 2022 /PRNewswire/ -- Nyra Medical, Inc., a medical device company that is...
Nov 18, 2022
CroíValve Reports Successful First in Human Implants of its DUO Tricuspid Coaptation Valve System
Dublin, Ireland, 18 November 2022 - CroíValve has announced the successful First in Human implants...
Oct 10, 2022
Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...
Sep 27, 2022
Puzzle Medical Devices Inc. Wins TCT 2022 Shark Tank Innovation Competition
NEW YORK – September 27, 2022 – The Cardiovascular Research Foundation (CRF) is pleased to...